The role of chronic inflammation on renal recovery after AKI
Project/Area Number |
15K19459
|
Research Category |
Grant-in-Aid for Young Scientists (B)
|
Allocation Type | Multi-year Fund |
Research Field |
Kidney internal medicine
|
Research Institution | Kumamoto University |
Principal Investigator |
Hayata Manabu 熊本大学, 医学部附属病院, 助教 (30646120)
|
Project Period (FY) |
2015-04-01 – 2017-03-31
|
Project Status |
Completed (Fiscal Year 2016)
|
Budget Amount *help |
¥3,900,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥900,000)
Fiscal Year 2016: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Fiscal Year 2015: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 急性腎障害 / 慢性腎臓病 / 慢性炎症 / AKI / CKD |
Outline of Final Research Achievements |
It is unclear how the underlying chronic inflammation in lifestyle-related diseases affects on the process of transition from AKI to CKD. In the chronic phase after IRI to the unilateral kidney of B6 mouse, the injured side kidney becomes atrophic. Although similar experiments were conducted using DIO and db/db mice as MetS models, a large amount of subcutaneous fats made it difficult to stabilize the IRI technical procedure enough to evaluate the chronic renal injury. Now, the pathway gene analysis by PCR array is in progress using chronic AKI tissues.
|
Report
(3 results)
Research Products
(14 results)
-
[Journal Article] A serine protease inhibitor attenuates aldosterone-induced kidney injuries via the suppression of plasmin activity.2016
Author(s)
Y. Kakizoe, Y. Miyasato, T. Onoue, T. Nakagawa, M. Hayata, K. Uchimura, J. Morinaga, T. Mizumoto, M. Adachi, T. Miyoshi, Y. Sakai, K. Tomita, M. Mukoyama, K. Kitamura
-
Journal Title
Journal of Pharmacological Sciences
Volume: 132
Issue: 2
Pages: 145-153
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
[Journal Article] Combination therapy with renin-angiotensin-aldosterone system inhibitor telmisartan and serine protease inhibitor camostat mesilate provides further renoprotection in a rat chronic kidney disease model.2016
Author(s)
Yuki Narita, Miki Ueda, Kohei Uchimura, Yutaka Kakizoe, Yoshikazu Miyasato, Teruhiko Mizumoto, Jun Morinaga, Manabu Hayata, Terumasa Nakagawa, Masataka Adachi, Taku Miyoshi, Yoshiki Sakai, Daisuke Kadowaki, Sumio Hirata, Masashi Mukoyama, Kenichiro Kitamura
-
Journal Title
Journal of Pharmacological Sciences
Volume: 130
Issue: 2
Pages: 110-116
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects.2015
Author(s)
Miki Ueda, Kohei Uchimura, Yuki Narita, Yoshikazu Miyasato, Teruhiko Mizumoto, Jun Morinaga, Manabu Hayata, Yutaka Kakizoe, Masataka Adachi, Taku Miyoshi, Naoki Shiraishi, Daisuke Kadowaki, Y Sakai, Masashi Mukoyama, Kenichiro Kitamura
-
Journal Title
Nephron
Volume: 129
Issue: 3
Pages: 223-232
DOI
Related Report
Peer Reviewed / Open Access / Acknowledgement Compliant
-
-
-
-
[Presentation] Doxycycline ameliorates cisplatin-induced nephrotoxicity in mice through directly acting on proximal tubular cells and promoting cell viability.2016
Author(s)
Terumasa Nakagawa, Yutaka Kakizoe, Naoki Suenaga, Yuki Narita, Yoshikazu Miyasato, Teruhiko Mizumoto, Manabu Hayata, Yuichiro Izumi, Takashige Kuwabara, Masataka Adachi, Hirofumi Jono, Hideyuki Saito, Kenichiro Kitamura, Masashi Mukoyama.
Organizer
American Society of Nephrology Kidney Week 2016
Place of Presentation
Chicago, IL
Year and Date
2016-11-15
Related Report
Int'l Joint Research
-
-
-
-
-
-